Atea Pharmaceuticals Inc. (AVIR) Cash Flow Statement Analysis - Operating Cash Flow, CapEx & Free Cash Flow - Stocknear
Stocknear Logo Stocknear
/
Popular
  • KO Coca Cola Company Stock
  • TSLA Tesla Inc Stock
  • AMD Advanced Micro Devices Stock
  • SPY SPDR S&P 500 ETF Trust ETF
  • NVDA Nvidia Stock
    • Start Trial

    Atea Pharmaceuticals Inc.

    NASDAQ: AVIR · Real-Time Price · USD
    2.92
    -0.01 (-0.34%)
    At close: Sep 29, 2025, 3:59 PM
    2.92
    0.00%
    After-hours: Sep 29, 2025, 04:44 PM EDT

    Atea Pharmaceuticals Cash Flow Statement

    Financials in USD. Fiscal year is January - December.

    undefined peaked at n/a in undefined and hit its lowest at n/a in undefined. Over the past five years, it has declined by undefined%.

    Fiscal Year FY 2024 FY 2023 FY 2022 FY 2021
    Period Ending Dec 31, 2024 Dec 31, 2023 Dec 31, 2022 Dec 31, 2021
    Net Income
    		 -168.38M -135.96M -115.91M 121.19M
    Depreciation & Amortization
    		 416K 416K 260K 29K
    Stock-Based Compensation
    		 51.77M 49.43M 46.72M 39.62M
    Other Working Capital
    		 -7.68M 14.46M -44.6M -258.13M
    Other Non-Cash Items
    		 -11.82M 33.11M -5.46M 29.39M
    Deferred Income Tax
    		 n/a -48.56M n/a -29.39M
    Change in Working Capital
    		 -7.48M 16.16M -46.59M -247.84M
    Operating Cash Flow
    		 -135.5M -85.39M -120.98M -87M
    Capital Expenditures
    		 n/a n/a -1.94M -4K
    Cash Acquisitions
    		 n/a n/a 453.47K n/a
    Purchase of Investments
    		 -461.18M -562.36M -545.35M n/a
    Sales Maturities Of Investments
    		 517.28M 602.66M 91.89M n/a
    Other Investing Acitivies
    		 n/a n/a -453.47K n/a
    Investing Cash Flow
    		 56.1M 40.3M -455.41M -4K
    Debt Repayment
    		 n/a n/a n/a n/a
    Common Stock Repurchased
    		 n/a n/a n/a n/a
    Dividend Paid
    		 n/a n/a n/a n/a
    Other Financial Acitivies
    		 n/a n/a 140K n/a
    Financial Cash Flow
    		 267K 257K 370K 1.47M
    Net Cash Flow
    		 -79.13M -44.84M -576.02M -85.54M
    Free Cash Flow
    		 -135.5M -85.39M -122.92M -87.01M

    Add to Watchlist